1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) inhibits cyclic GMP-PKG pathway-independent nonadrenergic, noncholinergic relaxation in longitudinal muscle of the rectum of Wistar-ST rats
M. Nakagawa et al., 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) inhibits cyclic GMP-PKG pathway-independent nonadrenergic, noncholinergic relaxation in longitudinal muscle of the rectum of Wistar-ST rats, JPN J PHARM, 82(2), 2000, pp. 164-167
Participation of the nitric oxide-cyclic GMP pathway in nonadrenergic, nonc
holinergic (NANC) relaxation induced by electrical field stimulation of lon
gitudinal muscle of the rectum of Wistar-ST rats was studied by using a sel
ective inhibitor of soluble guanylyl cyclase, 1H-[1,2,4]oxadiazolo[4,3-a]qu
inoxalin-1-one (ODQ), ODQ concentration dependently inhibited the relaxatio
n and at 10 mu M, maximally inhibited it by 83%. However, results obtained
with N-G-nitro-L-arginine, L-arginine and exogenously added nitric oxide ex
cluded the participation of nitric oxide in the relaxation. An inhibitor of
cyclic CMP-dependent protein kinase (PKG) partially (39%) inhibited the re
laxation. ODQ also significantly inhibited the relaxation, which persisted
after the PKC inhibitor-treatment, by 85%. The results strongly suggest tha
t ODQ inhibits the NANC relaxation in a cyclic GMP-PKG pathway-independent
manner.